Press Releases
Lando & Anastasi, LLP Expands Biotechnology/Pharmaceutical and Electrical/Computer Patent Teams
Lando and Anastasi, LLP today announced that Julie Gottselig, Dominic Yee, and Austin Kim have joined the firm. The Cambridge-based intellectual property law firm, one of the largest IP firms in New England, continues...
Press Releases
Genentech Data Showed That People With Metastatic Colorectal Cancer Lived Longer When They Continued on Avastin Plus Chemotherapy
Genentech, a member of the Roche Group, today announced results from ML18147, a Phase III study in metastatic colorectal cancer (mCRC) that evaluated Avastin® (bevacizumab) continued with second-line chemotherapy in people who received initial Avastin plus first-line chemotherapy. ...
Press Releases
Walgreens Statement on Express Scripts Dispute
Walgreens today issued the following statement about a dispute with Express Scripts, Inc. filed in September 2011: “The parties have agreed to dismiss their respective claims, and no other action has been or will...
Press Releases
ABPI and Teenage Cancer Trust CEOs in Keynote Debate at Patient Summit 2012 eyeforpharma
Stephen Whitehead, CEO of The Association of the British Pharmaceutical Industry (ABPI) and Simon Davies, CEO of Teenage Cancer Trust will engage in the Keynote Debate at the Patient Summit 2012, it has been announced. ...
Press Releases
Rhenovia files patents for new treatment of Huntington’s disease based on its innovative biosimulation platform
Rhenovia Pharma, a leading biotech company in biosimulation applied to the discovery of new medications to treat neurodegenerative, neurological and psychiatric diseases, announces today the filing of patents of a new method, a drug candidate, RHEDAR(TM) and a...
Press Releases
Ariana(R) expands operations to USA, appoints James M. Shanahan VP business development of subsidiary “Ariana Data Intelligence, Inc.”
Ariana Pharma, a provider of “non-statistical” clinical data analysis technology to the pharmaceutical industry including the FDA, announces today that it has expanded its global operations by establishing a permanent US office in Cambridge, Massachusetts to service growing...
Press Releases
Cure for Traumatic Brain Injury May be in Sight Rainbow Coral Corp
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., continues due diligence toward an agreement to help develop a promising new treatment for Traumatic Brain Injury (TBI), concern continues to grow over the troubling incidence of TBI among...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















